Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy

At Andelyn Biosciences, we are proud to introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development. Our Analytical Development and Quality Control teams work in seamless collaboration, ensuring a robust focus on GMP analytics—critical for upholding the integrity and compliance of our clinical-phase productions. This synergy enables manufacturing processes that adhere strictly to the highest regulatory standards, fostering trust and reliability in every step of our work.

The journey of each assay begins within the Analytical Development team, where it is meticulously designed and rigorously tested in an R&D quality control environment. Before transitioning to operational use within our GMP Quality Control framework, these assays undergo stringent regulatory scrutiny to ensure their accuracy, precision, and compliance. This carefully structured approach not only underscores our industry leadership but also exemplifies our unwavering dedication to supporting our partners in achieving their pharmaceutical development goals.